Literature DB >> 22054726

The optimal dose of recombinant human osteogenic protein-1 enhances differentiation of mouse osteoblast-like cells: an in vitro study.

Feng Zhang1, Ling-fei Ren, Hai-sheng Lin, Mei-nv Yin, Yong-qing Tong, Geng-sheng Shi.   

Abstract

OBJECTIVE: There is no certain conclusion on the effect of recombinant human Osteogenic Protein-1 (OP-1, BMP-7) on the proliferation of the osteoblast-like cell line, MC3T3-E1. Furthermore, the optimal dose of rhOP-1 on cell differentiation still needs to be elucidated. This investigation aims to delineate the biofunctional characteristics of rhOP-1 in inducing osteoblastogenesis of MC3T3-E1 through in vitro time-course and dose-response studies.
DESIGN: MC3T3-E1 cells were cultured for 1, 4, 7 days with the addition of different rhOP-1 concentrations (0, 10, 20, 50, 100, 200, 400 ng/ml), and cell proliferation and cell differentiation were examined.
RESULTS: MC3T3-E1 cell proliferation was stimulated by rhOP-1 in a dose-dependent manner (0-400 ng/ml) on day 1, whereas on day 4 and 7, it was still stimulated at low concentrations (10, 20, 50 ng/ml) but inhibited at high ones (200, 400 ng/ml). The alkaline phosphatase (ALP) activity, osteocalcin (OC) production, collagen deposition and extracellular matrix mineralization were dramatically elevated by rhOP-1 treatment, as a function of culture time and rhOP-1 concentration, and all of them reached a plateau at the concentration of 200 ng/ml. Real-time quantitative RT-PCR results showed Runx2, AKP-2, OC and Nog mRNA expressions increased in a dose- and time-dependent manner, and their expressions were significantly higher at high rhOP-1 concentrations than that of low ones. No significant differences were found between the effects of 200 ng/ml rhOP-1 and 400 ng/ml rhOP-1 on the differentiation of MC3T3-E1 cells, except the expression of Nog mRNA, whose expression level was much higher at 400 ng/ml than that at 200 ng/ml.
CONCLUSIONS: These results suggest that cell proliferation of MC3T3-E1 is depended on culture time and rhOP-1 concentration, rhOP-1 could stimulate the differentiation of MC3T3-E1 cells and the optimal concentration could be 200 ng/ml.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22054726     DOI: 10.1016/j.archoralbio.2011.10.008

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  5 in total

1.  Growth Factor-Loaded Microparticles for Tissue Engineering: The Discrepancies of In Vitro Characterization Assays.

Authors:  Nathalie Bock; Tim R Dargaville; Giles T S Kirby; Dietmar W Hutmacher; Maria A Woodruff
Journal:  Tissue Eng Part C Methods       Date:  2015-12-14       Impact factor: 3.056

2.  Coating Ti6Al4V implants with nanocrystalline diamond functionalized with BMP-7 promotes extracellular matrix mineralization in vitro and faster osseointegration in vivo.

Authors:  Ivana Nemcakova; Andrej Litvinec; Vaclav Mandys; Stepan Potocky; Martin Plencner; Martina Doubkova; Ondrej Nanka; Veronika Olejnickova; Barbora Sankova; Martin Bartos; Egor Ukraintsev; Oleg Babčenko; Lucie Bacakova; Alexander Kromka; Bohuslav Rezek; David Sedmera
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

3.  Effects of rmBMP-7 on Osteoblastic Cells Grown on a Nanostructured Titanium Surface.

Authors:  Leonardo Raphael Zuardi; Fabíola Singaretti de Oliveira; Roger Rodrigo Fernandes; Maria Paula Oliveira Gomes; Silvia Spriano; Antonio Nanci; Paulo Tambasco de Oliveira
Journal:  Biomimetics (Basel)       Date:  2022-09-16

4.  The effects of immunomodulation by macrophage subsets on osteogenesis in vitro.

Authors:  Florence Loi; Luis A Córdova; Ruth Zhang; Jukka Pajarinen; Tzu-hua Lin; Stuart B Goodman; Zhenyu Yao
Journal:  Stem Cell Res Ther       Date:  2016-01-22       Impact factor: 6.832

5.  Engineered Coatings for Titanium Implants To Present Ultralow Doses of BMP-7.

Authors:  Mohammed Al-Jarsha; Vladimíra Moulisová; Aldo Leal-Egaña; Andrew Connell; Kurt B Naudi; Ashraf F Ayoub; Matthew J Dalby; Manuel Salmerón-Sánchez
Journal:  ACS Biomater Sci Eng       Date:  2018-04-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.